Eikon Therapeutics Inc. Insider Trading

EIKN

⊜ Compare

Last 12 months

Insiders bought $7M on the open market and sold nothing.

Net open-market

+$7M

2 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

2 / 0

executives and directors

Last open-market buy

Feb 2026

Feb 4, 2026

Get an email when EIKN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 3	Tim Kutzkey Large holder	Bought	89,200	$11.56	$1.03M	1.5%	Form 4
Feb 6	Column Group Opportunity Iii, LP Large holder	Bought 3 parts	2,117,760	$18.00 average	$38.1M	58%	Form 4
Feb 4	Kenneth C Frazier Director	Bought	111,111	$18.00	$2M	New	Form 4
Feb 4	Josh Wolfe Director	Bought 2 parts	277,776	$18.00 average	$5M	14%	Form 4
Feb 4	Lux Ventures V, L.p. Large holder	Bought 2 parts	277,776	$18.00 average	$5M	14%	Form 4
Feb 4	Foresite Capital Opportunity Management V, LLC Large holder	Bought	55,555	$18.00	1000K	4.4%	Form 4

Sep 3
Tim Kutzkey
Large holder · bought 89,200 at $11.56
$1.03M
1.5% of stake
Feb 6
Column Group Opportunity Iii, LP
Large holder · bought 2,117,760 at avg $18.00
$38.1M
58% of stake
Feb 4
Kenneth C Frazier
Director · bought 111,111 at $18.00
$2M
New position
Feb 4
Josh Wolfe
Director · bought 277,776 at avg $18.00
$5M
14% of stake
Feb 4
Lux Ventures V, L.p.
Large holder · bought 277,776 at avg $18.00
$5M
14% of stake
Feb 4
Foresite Capital Opportunity Management V, LLC
Large holder · bought 55,555 at $18.00
1000K
4.4% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch EIKN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biotechnology · Pick stocks to compare with EIKN

CompareIntrinsic value

NEWBRY.XSTONewbury Pharmaceuticals AB

€0.08+15.03%40

HPHA.XETRHeidelberg Pharma AG

€2.01-3.37%10

MEDCL.XPARMedincell SA

€28.68+3.02%40

ZTEKZentek Ltd.

€0.33+0.60%40

XTXXFAdastra Holdings Ltd.

€0.08+0.00%40

XRTXXORTX Therapeutics Inc.

$0.99-1.00%10

VALNValneva SE Sponsored ADR

$5.63+2.18%0

TRIBTrinity Biotech plc Sponsored ADR

$6.43-2.02%10

Held by ETFs

EIKN is in 7 US ETFs. The largest of them, with EIKN's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing EIKN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.